[PHARMA] QoQ TTM Result on 30-Sep-2013 [#3]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
19-Nov-2013
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2013
Quarter
30-Sep-2013 [#3]
Profit Trend
QoQ- -44.83%
YoY- -67.58%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
TTM Result
30/06/14 31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 CAGR
Revenue 2,002,411 1,914,972 1,946,639 1,861,183 1,846,836 1,865,940 1,812,346 6.89%
PBT 109,249 94,232 92,997 64,238 79,270 97,283 103,314 3.80%
Tax -41,209 -35,978 -36,236 -36,212 -29,878 -37,985 -40,108 1.82%
NP 68,040 58,254 56,761 28,026 49,392 59,298 63,206 5.04%
-
NP to SH 66,756 56,646 55,200 26,453 47,949 57,797 61,711 5.39%
-
Tax Rate 37.72% 38.18% 38.96% 56.37% 37.69% 39.05% 38.82% -
Total Cost 1,934,371 1,856,718 1,889,878 1,833,157 1,797,444 1,806,642 1,749,140 6.96%
-
Net Worth 502,293 515,022 486,672 473,402 480,568 484,829 472,037 4.24%
Dividend
30/06/14 31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 CAGR
Div 44,519 42,973 41,446 37,168 41,172 41,189 41,188 5.33%
Div Payout % 66.69% 75.86% 75.08% 140.51% 85.87% 71.27% 66.74% -
Equity
30/06/14 31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 CAGR
Net Worth 502,293 515,022 486,672 473,402 480,568 484,829 472,037 4.24%
NOSH 258,914 258,805 258,868 258,689 258,370 117,676 117,715 69.37%
Ratio Analysis
30/06/14 31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 CAGR
NP Margin 3.40% 3.04% 2.92% 1.51% 2.67% 3.18% 3.49% -
ROE 13.29% 11.00% 11.34% 5.59% 9.98% 11.92% 13.07% -
Per Share
30/06/14 31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 CAGR
RPS 773.39 739.93 751.98 719.47 714.80 1,585.65 1,539.60 -36.88%
EPS 25.78 21.89 21.32 10.23 18.56 49.11 52.42 -37.77%
DPS 17.20 16.61 16.01 14.37 15.94 35.00 35.00 -37.80%
NAPS 1.94 1.99 1.88 1.83 1.86 4.12 4.01 -38.45%
Adjusted Per Share Value based on latest NOSH - 258,689
30/06/14 31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 CAGR
RPS 138.94 132.87 135.07 129.14 128.14 129.47 125.75 6.89%
EPS 4.63 3.93 3.83 1.84 3.33 4.01 4.28 5.39%
DPS 3.09 2.98 2.88 2.58 2.86 2.86 2.86 5.30%
NAPS 0.3485 0.3573 0.3377 0.3285 0.3334 0.3364 0.3275 4.24%
Price Multiplier on Financial Quarter End Date
30/06/14 31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 CAGR
Date 30/06/14 31/03/14 31/12/13 30/09/13 28/06/13 29/03/13 31/12/12 -
Price 4.61 4.46 4.45 4.82 4.49 8.26 8.10 -
P/RPS 0.60 0.60 0.59 0.67 0.63 0.52 0.53 8.64%
P/EPS 17.88 20.38 20.87 47.14 24.19 16.82 15.45 10.25%
EY 5.59 4.91 4.79 2.12 4.13 5.95 6.47 -9.31%
DY 3.73 3.72 3.60 2.98 3.55 4.24 4.32 -9.35%
P/NAPS 2.38 2.24 2.37 2.63 2.41 2.00 2.02 11.58%
Price Multiplier on Announcement Date
30/06/14 31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 CAGR
Date 21/08/14 14/05/14 24/02/14 19/11/13 16/08/13 15/05/13 18/02/13 -
Price 4.62 4.70 4.29 4.72 4.66 9.26 7.80 -
P/RPS 0.60 0.64 0.57 0.66 0.65 0.58 0.51 11.47%
P/EPS 17.92 21.47 20.12 46.16 25.11 18.85 14.88 13.23%
EY 5.58 4.66 4.97 2.17 3.98 5.30 6.72 -11.68%
DY 3.72 3.53 3.73 3.04 3.42 3.78 4.49 -11.81%
P/NAPS 2.38 2.36 2.28 2.58 2.51 2.25 1.95 14.24%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment